Why Medicine Costs So Much Money, Despite Imports from Low-Cost Nations
The Senate Commerce Committee takes the little known, and even less understood, Pharmacy Benefit Manager industry to task for high drug costs.
The Senate Commerce Committee takes the little known, and even less understood, Pharmacy Benefit Manager industry to task for high drug costs.
The Senate Committee on Finance discusses trade, as witnesses led by FedEx throw support behind the de minimis duty-free imports rule.
What are the risks China poses to the U.S. industrial supply chain and what can be done about it? Some quotes from Congress and witnesses from a Feb. 7 hearing.
Notes from the recent Senate Foreign Relations Committee hearing on China. What the No. 2 at State said about China and U.S. supply chain risk.
A bipartisan trio of Senators sent a letter to China retailer SHEIN asking for assurances their clothes sold here are not made with banned cotton. They also inquire about the de minimis loophole that makes SHEIN possible.
A new report by the Government Accountability Office highlights the need for revamped trade deals. But missing from the discussion is the case for more local supply chains.
The latest trade figures show historic deficits with Mexico, Canada and Vietnam. Meanwhile, the 2022 deficit with China and the EU is the second largest of all time.
Yes, in many ways the U.S. is funding China’s defense sector through venture capital, portfolio investments, and computer hardware sales to companies on the Entity List.
On January 31, CPA trade counsel Charles Benoit gives a masters class on the history of trade tariffs, and how they were used to build the U.S. economy.
The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?